Skip to content
MedCompare

Finerenone

Heart & Blood Pressure
Save $604/mo
23× cheaper

Kerendia is indicated to reduce the risk of: sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2DM).

United States
$632
per month
India
$28
per month
You save
−96%
save $604/mo · 96% cheaper
403.6K US scripts/yr$243.8M potential annual savings$255M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC21H22N4O3

SMILES: CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C

Compare the price
US price$632per month
India price$28per month
You save$60496% less

Based on 30 units per month. US $21.06 vs India $0.93 per unit.

Total over 1 periodSave $604$632 → $28
The bigger picture

Finerenone is filled about 403.6K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$255M
If sourced from India
$11.3M
Potential annual savings
$243.8M
−96%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.